Interventions for Amphetamine Misuse

Interventions for Amphetamine Misuse is a practical, useable
guide for health professionals working in the field. It details the
physical and psychological problems associated with the drug's
abuse, provides a detailed and evidence-based assessment of the
interventions currently in use worldwide, and offers a broad
historical and cultural overview. The book includes detailed case
studies to illustrate the experiences of a wide range of countries
including the UK, Japan, Australia, Thailand, and the USA with the
aim of drawing together the evidence and reaching a consensus.

This important book also offers an overview of the changes in
legislation that have reflected growing concern regarding the
evolution in the way that the substance has been formulated.
Discussed are the illicit use of amphetamine type substances and
the associated dangers and concerns with the treatment of attention
deficit hyperactivity disorder and the drug's use in the
suppression of appetite.

Auteur

Richard Pates is a consultant clinical psychologist and
clinical director of the Addiction services for Cardiff and vale
NHS Trust. He has worked in the field for nearly 20 years and has
extensive experience of treating people with amphetamine problems.
His research interests include the treatment of amphetamine
problems and aspects of injecting. He is also editor of The Journal
of Substance Use.

Diane Riley is the Director of the Harm Reduction
Network, a policy analyst with the Canadian Foundation for Drug
Policy and the International Harm Reduction Association, and a
Professor in the Faculty of Medicine at the University of Toronto,
Canada.

Résumé
Interventions for Amphetamine Misuse is a practical, useable guide for health professionals working in the field. It details the physical and psychological problems associated with the drug's abuse, provides a detailed and evidence-based assessment of the interventions currently in use worldwide, and offers a broad historical and cultural overview. The book includes detailed case studies to illustrate the experiences of a wide range of countries including the UK, Japan, Australia, Thailand, and the USA with the aim of drawing together the evidence and reaching a consensus. This important book also offers an overview of the changes in legislation that have reflected growing concern regarding the evolution in the way that the substance has been formulated. Discussed are the illicit use of amphetamine type substances and the associated dangers and concerns with the treatment of attention deficit hyperactivity disorder and the drug's use in the suppression of appetite.

Contenu

Contributors.

Dedication.

Acknowledgements.

1. Introduction (Richard Pates and Diane Riley).

2. The physical effects of amphetamine use (Zoe Hildrey,
   Sophie E. Thomas and Alyson Smith).

3. The psychological and psychiatric effects of amphetamines
   (Richard Pates and Diane Riley).

4. The mechanisms of amphetamine in the brain (Jan K.
   Melichar and David J. Nutt).

5. Methylphenidate for the treatment of ADHD: clinical efficacy,
   abuse potential and consequences of use (Craig R. Rush, Andrea
   R. Vansickel, William W. Stoops and Paul E. A. Glaser).

6. Amphetamine treatment in the UK: the role of substitute
   prescribing (Richard Pates).

7. Treatments for methamphetamine dependence: contingency
   management and the matrix model (Richard A. Rawson).

8. Amphetamine use in Canada (Diane Riley).

9. Treatment responses to problematic methamphetamine use: the
   Australian experience (James Shearer).

10. The 'P' problem in New Zealand (Chris Wilkins
    and Janie Sheridan).

11 Japan's long association with amphetamines: what can we
learn from their experiences? (Akihiko Sato).

12. The emergence of methamphetamine in Thailand: interventions
    and treatment (Anjalee Cohen and Catherine McGregor).

13. Stimulant use in Central and Eastern Europe: how recent
    social history shaped current drug consumption patterns
    (Jean-Paul Grund, Tomas Zabransky, Kevin S. Irwin and Robert
    Heimer).

14. Sweden's long experience of amphetamine problems
    (Kerstin Käll).

15. Harm reduction and amphetamines (Diane Riley).

16. What have we learned: conclusions on treatment (Diane
    Riley and Richard Pates).

Index.